Zentalis Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $575k | 381k | 1.51 |
| 2025-06-30 | $365k | 315k | 1.16 |
| 2025-03-31 | $574k | 361k | 1.59 |
| 2024-12-31 | $1.0M | 345k | 3.03 |
| 2024-09-30 | $843k | 229k | 3.68 |
| 2024-06-30 | $414k | 101k | 4.09 |
| 2024-03-31 | $307k | 20k | 15.76 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management